ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Clinical trial NCT01663402 · COMPLETED

Trial details

NCT number: NCT01663402
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease

Start date: 2012-10-01
Primary completion: 2018-01-23
Enrollment: 18924

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.